APTARGROUP, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that APTARGROUP, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $3.58B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $3.49B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $3.32B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $3.23B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $2.93B | Feb 17, 2023 |
| FY2019 | Dec 31, 2019 | $671.33M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $701.28M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $742.66M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $744.46M | Feb 24, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.78B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $3.58B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $3.49B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $3.32B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $3.23B | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | $749.33M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $759.15M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $699.31M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $721.55M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $671.33M | Feb 19, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $625.90M | Feb 26, 2018 |
| FY2017 | Sep 30, 2017 | $624.33M | Feb 26, 2018 |
| FY2017 | Jun 30, 2017 | $617.75M | Feb 26, 2018 |
| FY2017 | Mar 31, 2017 | $601.32M | Feb 26, 2018 |
| FY2017 | Dec 31, 2016 | $538.87M | Feb 26, 2018 |
| FY2017 | Sep 30, 2016 | $589.73M | Feb 26, 2018 |
| FY2017 | Jun 30, 2016 | $620.00M | Feb 26, 2018 |
| FY2017 | Mar 31, 2016 | $582.34M | Feb 26, 2018 |
| FY2016 | Dec 31, 2015 | $546.77M | Feb 27, 2017 |
| FY2016 | Sep 30, 2015 | $586.29M | Feb 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $231.02M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $233.99M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $213.49M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $227.51M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $193.59M | Feb 19, 2021 |
| FY2020 | Sep 30, 2019 | $215.22M | Feb 19, 2021 |
| FY2020 | Jun 30, 2019 | $231.74M | Feb 19, 2021 |
| FY2020 | Mar 31, 2019 | $233.84M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $184.78M | Feb 24, 2020 |
| FY2019 | Sep 30, 2018 | $192.54M | Feb 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $392.79M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $374.54M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $284.49M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $239.29M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $244.10M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $214.04M | Feb 17, 2023 |
| FY2010 | Dec 31, 2010 | $173.48M | Feb 25, 2011 |
| FY2010 | Dec 31, 2009 | $124.62M | Feb 25, 2011 |
| FY2010 | Dec 31, 2008 | $153.50M | Feb 25, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $501.04M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $496.50M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $404.02M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $379.27M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $347.35M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $339.50M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $371.69M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $286.27M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $323.49M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $313.69M | Feb 21, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $105.10M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $96.10M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $92.80M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $93.50M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $99.80M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $92.50M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $82.80M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $75.30M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $68.20M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $66.20M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $570.00M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $643.41M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $575.24M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $478.62M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $363.44M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $570.15M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $514.46M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $313.63M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $324.73M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $325.30M | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.42M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $276.48M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $312.34M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $310.43M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $307.94M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $245.95M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $242.28M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $211.25M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $156.62M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $128.99M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.25B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $4.43B | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $4.45B | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $4.20B | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $4.14B | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $3.99B | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $3.56B | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $3.38B | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $3.14B | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $2.61B | Feb 21, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.67B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $2.47B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $2.31B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $2.05B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $1.97B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.85B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.57B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.42B | Feb 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.31B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.17B | Feb 26, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.08B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $936.26M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $963.42M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $945.63M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $974.16M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $898.52M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $763.46M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $712.10M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $443.89M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $407.52M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.64B | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $2.37B | Feb 6, 2026 |
| FY2024 | Dec 31, 2023 | $2.11B | Feb 7, 2025 |
| FY2023 | Dec 31, 2022 | $1.93B | Feb 9, 2024 |
| FY2022 | Dec 31, 2021 | $1.79B | Feb 17, 2023 |
| FY2021 | Dec 31, 2020 | $1.64B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.52B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.37B | Feb 24, 2020 |
| FY2019 | Jan 1, 2018 | $1.30B | Feb 24, 2020 |
| FY2019 | Dec 31, 2017 | $1.30B | Feb 24, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $402.42M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $223.84M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $223.64M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $141.73M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $122.93M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $300.14M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $241.97M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $261.82M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $712.64M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $466.29M | Feb 21, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 9, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.78M | Feb 6, 2026 |
| FY2025 | Dec 31, 2024 | $114.06M | Feb 6, 2026 |
| FY2025 | Dec 31, 2023 | $103.68M | Feb 6, 2026 |
| FY2024 | Dec 31, 2022 | $99.46M | Feb 7, 2025 |
| FY2023 | Dec 31, 2021 | $98.51M | Feb 9, 2024 |
| FY2022 | Dec 31, 2020 | $92.66M | Feb 17, 2023 |
| FY2021 | Dec 31, 2019 | $90.21M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $82.35M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $79.94M | Feb 24, 2020 |
| FY2018 | Dec 31, 2016 | $76.66M | Feb 21, 2019 |